Leading Fertility Testing Devices Purchase Mode Markets Databank
The Fertility Testing Devices market was valued at $580.3 Million in 2020, and is projected to reach $1,810.0 Million by 2029 growing at a CAGR of 13.52% from 2021 to 2029. OTC segment is expected to be the highest contributor to this market, with $436.9 Million in 2020, and is anticipated to reach $1,358.1 Million by 2029, registering a CAGR of 13.48%. Prescription segment is anticipated to reach $451.9 Million by 2029 with the highest CAGR of 13.64%. Prescription and OTC segments are expected to witness significant growth rates at a CAGR of 13.64% and 13.48% respectively, during the forecast period.
- 1. GLOBAL FERTILITY TESTING DEVICES MARKET, BY PURCHASE MODE
- 1.1. OVERVIEW
- 1.2. OTC
- 1.2.1 OTC MARKET, BY REGION
- 1.2.1.1 North America OTC Market, By Country
- 1.2.1.2 Europe OTC Market, By Country
- 1.2.1.3 Asia-Pacific OTC Market, By Country
- 1.2.1.4 Rest of World OTC Market, By Country
- 1.3. PRESCRIPTION
- 1.3.1 PRESCRIPTION MARKET, BY REGION
- 1.3.1.1 North America Prescription Market, By Country
- 1.3.1.2 Europe Prescription Market, By Country
- 1.3.1.3 Asia-Pacific Prescription Market, By Country
- 1.3.1.4 Rest of World Prescription Market, By Country
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook